8-KThe WireStrategic
Exit / Disposal Costs
Filed Apr 28, 2026 · 2mo ago · Accession 0001104659-26-049755
Plain English
Passage Bio, Inc. announced a restructuring plan on April 28, 2026, to decrease operating expenses by reducing its workforce by approximately 75%. The company expects aggregate severance and exit costs for this plan to be approximately $3.3 million.
Filing details
- Company
- Passage BIO, Inc.
- Ticker
- PASG
- CIK
- 1787297
- Form type
- 8-K
- Filing date
- Apr 28, 2026
- Report date
- Apr 28, 2026
- Document
- tm2612859d1_8k.htm
- Size
- 189 KB